Creative Medical Technology announced that its Board of Directors has approved a share repurchase program. The program authorizes the company to repurchase up to $2M of its shares of common stock, in the open market or through privately negotiated transactions, in accordance with applicable securities laws and other restrictions. The program has no termination date, may be suspended or discontinued at any time, and does not obligate the company to acquire any particular number of shares of common stock.
Published first on TheFly
